SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

LAB

Standard Biotools Inc.
NASDAQHealth Care

Latest close: 0.63 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 30, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,46810 flagged findings
Reported transactions (Form 4)80since Jan 5, 2024 · and 8 other holdings
Corporate events (8-K)30since Jan 5, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jul 24, 2026).

Deadline: Jan 18, 2027

  • minimum bid price · Nasdaq, rule 5450(a)(1) · notice of Jul 22, 2026 · transferred, still open · deadline Jan 18, 2027 (text and rule agree)

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,468)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 26S-4/A ↗Merger, acquisition or tender offer · amendment
  • Oct 5, 26Form 425 ↗Merger, acquisition or tender offer
  • Oct 5, 268-K ↗Current report · Communication to the market
  • Sep 30, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 30, 268-K ↗Current report · Entered a material agreement
  • Sep 9, 26S-4/A ↗Merger, acquisition or tender offer · amendment
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · MAK CAPITAL ONE LLC · 7.3% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · LONG FOCUS CAPITAL MANAGEMENT, LLC · 6.0% · event on Jun 30, 26
  • Aug 5, 268-K ↗Current report · Results · Communication to the market
  • Aug 5, 2610-Q ↗Quarterly report
  • Aug 4, 26Form 4 ↗Insider transaction
  • Jul 30, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 2.0% · event on Jun 30, 26 · amendment
  • Jul 29, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 29, 268-K/A ↗Current report · Financial statements and exhibits · amendment
  • Jul 28, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 28, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 28, 268-K ↗Current report · Entered a material agreement
  • Jul 27, 26Form 4 ↗Insider transaction
  • Jul 24, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Jul 20, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 20, 26S-4 ↗Merger, acquisition or tender offer
  • Jun 23, 26Form 4 ↗Insider transaction

1,468 filings on record, the oldest from Feb 9, 11.

Listing the 25 most recent filings of the 1,468 on record.

8-Ks, explained

Stress6Structure62Governance63
  • Sep 30, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jul 28, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 24, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 18, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 8, 26StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Jun 3, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • May 28, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 24, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 30, 26StructureCompleted an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
  • Sep 17, 25StressRestructuring plan with committed costs8-K 2.05 ↗
  • Sep 3, 25StressRestructuring plan with committed costs8-K 2.05 ↗
  • Aug 1, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗

11 older filings not shown · The record reaches back to Mar 15, 11.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 25, 24StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Aug 8, 22StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Eli Casdin23.9%Jun 6, 26SCHEDULE 13D/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • VIKING GLOBAL INVESTORS LP15.0%Jun 6, 26SCHEDULE 13D ↗10 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • VIKING GLOBAL INVESTORS LP15.0%Mar 31, 26SCHEDULE 13G/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum.
  • MAK CAPITAL ONE LLC7.3%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • MAK Capital Fund LP6.7%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • LONG FOCUS CAPITAL MANAGEMENT, LLC6.0%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.2.0%Jun 30, 26SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Dec 4, 25Buy$217KCasdin Partners Master Fund, L.P.↗
  • Dec 3, 25Buy$108KCasdin Partners Master Fund, L.P.↗
  • Dec 2, 25Buy$178KCasdin Partners Master Fund, L.P.↗
  • Nov 25, 25Buy$9.8MCasdin Partners Master Fund, L.P.↗
  • Nov 24, 25Buy$215KCasdin Partners Master Fund, L.P.↗
  • Nov 20, 25Buy$586KCasdin Partners Master Fund, L.P.↗
  • Nov 19, 25Buy$449KCasdin Partners Master Fund, L.P.↗
  • Nov 18, 25Buy$339KCasdin Partners Master Fund, L.P.↗
  • Nov 17, 25Buy$276KCasdin Partners Master Fund, L.P.↗
Stock compensation, tax and giftsshow the 31 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 20, 26Tax$66KMichael EgholmPresident & CEO↗
  • Aug 20, 26Tax$19KHanjoon Alex KimChief Financial Officer↗
  • Aug 20, 26Tax$17KSean MackaySVP & Chief Business Officer↗
  • Aug 3, 26Tax$315KMichael EgholmPresident & CEO↗
  • Jul 23, 26Tax$181KHanjoon Alex KimChief Financial Officer↗
  • Jun 20, 26Compensationamount n/aSean MackaySVP & Chief Business Officer↗
  • Jun 18, 26Compensationamount n/aKATHY L HIBBS↗
  • Jun 18, 26Compensationamount n/aFENEL M ELOI↗
  • Jun 18, 26Compensationamount n/aTroy Cox↗
  • Jun 18, 26Compensationamount n/aEli Casdin↗
  • Jun 18, 26Compensationamount n/aFrank Witney↗
  • Jun 18, 26Compensationamount n/aThomas D. Carey↗
  • May 20, 26Tax$98KMichael EgholmPresident & CEO↗
  • May 20, 26Tax$26KSean MackaySVP & Chief Business Officer↗
  • May 20, 26Tax$19KHanjoon Alex KimChief Financial Officer↗
  • Apr 6, 26Compensationamount n/aHanjoon Alex KimChief Financial Officer↗
  • Apr 6, 26Tax$19KHanjoon Alex KimChief Financial Officer↗
  • Apr 6, 26Compensationamount n/aMichael EgholmPresident & CEO↗
  • Apr 6, 26Tax$86KMichael EgholmPresident & CEO↗
  • Mar 20, 26Compensationamount n/aHanjoon Alex KimChief Financial Officer↗
  • Mar 20, 26Compensationamount n/aSean MackaySVP & Chief Business Officer↗
  • Mar 20, 26Compensationamount n/aMichael EgholmPresident & CEO↗
  • Feb 26, 26Compensation$60KThomas D. Carey↗
  • Feb 26, 26Compensation$67KTroy Cox↗
  • Feb 26, 26Compensation$62KEli Casdin↗
  • Feb 23, 26Tax$15KHanjoon Alex KimChief Financial Officer↗
  • Feb 23, 26Tax$23KSean MackaySVP & Chief Business Officer↗
  • Feb 23, 26Tax$76KMichael EgholmPresident & CEO↗
  • Nov 20, 25Tax$25KSean MackaySVP & Chief Business Officer↗
  • Nov 20, 25Tax$16KHanjoon Alex KimChief Financial Officer↗
  • Nov 20, 25Tax$81KMichael EgholmPresident & CEO↗

The full record holds 183 transactions and goes back to Dec 20, 22.

Its sector and its market

Standard Biotools Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Standard Biotools Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Standard Biotools Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,468 documents on file, from Feb 9, 2011 to Oct 9, 2026.
Company description
Wikipedia, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Standard Biotools Inc. (LAB): stock price history, insider trades and SEC filings — HornScout